Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Gains from Sales and Divestitures (2020 - 2025)

NovaBridge Biosciences (NBP) reported Gains from Sales and Divestitures of $910939.0 for Q4 2025, up 1038.04% on a QoQ basis from $80044.4 in Q4 2023.

NovaBridge Biosciences (NBP) has 5 years of Gains from Sales and Divestitures data on file, last reported at $910939.0 in Q4 2025.

  • Quarterly Gains from Sales and Divestitures changed N/A year-over-year to $910939.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $910939.0 (changed N/A YoY) and the FY2025 annual result came in at $910939.0, changed N/A from the prior year.
  • Gains from Sales and Divestitures improved to $910939.0 in Q4 2025 per NBP's latest filing, from $80044.4 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $910939.0 in Q4 2025 and bottomed at $80044.4 in Q4 2023.
  • The 4-year median for Gains from Sales and Divestitures is $110297.8 (2021), against an average of $302894.7.
  • The widest annual swing landed in 2021, when Gains from Sales and Divestitures soared 39.92%; it then declined 20.96% in 2023.
  • Tracing NBP's Gains from Sales and Divestitures over 4 years: stood at $119328.0 in 2021, then decreased by 15.14% to $101267.6 in 2022, then declined by 20.96% to $80044.4 in 2023, then jumped by 1038.04% to $910939.0 in 2025.
  • Per Business Quant, the three latest NBP Gains from Sales and Divestitures figures stand at $910939.0 (Q4 2025), $80044.4 (Q4 2023), and $101267.6 (Q4 2022).

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 910,939.00
Dec 31, 2025 910,939.00
Dec 31, 2023 80,044.42
Dec 31, 2023 80,044.42
Dec 31, 2022 101,267.56
Dec 31, 2022 101,267.56
Dec 31, 2021 119,328.01
Dec 31, 2021 119,328.01
Dec 31, 2020 85,284.89
Dec 31, 2020 85,284.89